Clinical Trial Update: A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 RIPT study evaluating the sensitization potential of topical SM04755 solution in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tendinopathy

Drugs mentioned

• SM04755 topical solution (SM04755)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Tendinopathy | Phase 1 | Status: COMPLETED